Stay updated on Epacadostat + Durvalumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page.

Latest updates to the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, indicating a minor maintenance update. No study details, eligibility criteria, or other user-facing content were modified.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedFooter now shows Revision: v3.6.5, replacing the previous v3.6.4; this indicates a small site update and does not change the study information displayed on the page.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This appears to be a minor maintenance update with no changes to study content or data visible on the page.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3; the page's content and structure related to the study details remain unchanged.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a minor build/format update to the study details page without altering its substantive content.SummaryDifference0.1%

- Check88 days agoChange DetectedRecruitment has been closed, as indicated by the new 'No longer looking for participants' note on the study page. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment header formatting was updated, and the page footer shows Revision: v3.6.0.SummaryDifference0.4%

Stay in the know with updates to Epacadostat + Durvalumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page.